A New Drug to Treat Focal Segmental Glomerulosclerosis and Renewed Hope for Vertex Pharmaceuticals

After several clinical setbacks, Vertex Pharmaceuticals found promising results in its study of a drug to treat a genetic kidney disease called focal segmental glomerulosclerosis (FSGS). As reported recently by…

Continue Reading A New Drug to Treat Focal Segmental Glomerulosclerosis and Renewed Hope for Vertex Pharmaceuticals
Unmet Needs in the Treatment of Certain Glomerular Diseases
source: pixabay.com

Unmet Needs in the Treatment of Certain Glomerular Diseases

by Lauren Taylor from In The Cloud Copy Nephrologists worldwide have shown that there is a huge unmet need when it comes to the treatment of various glomerular diseases, in…

Continue Reading Unmet Needs in the Treatment of Certain Glomerular Diseases
All Patients Enrolled in Sparsentan Trial for FSGS
Photo by Robina Weermeijer on Unsplash

All Patients Enrolled in Sparsentan Trial for FSGS

On November 30, 2020, biopharmaceutical company Travere Therapeutics ("Travere") announced that patient enrollment was complete for the Phase 3 DUPLEX clinical trial. Within the trial, researchers will evaluate the safety,…

Continue Reading All Patients Enrolled in Sparsentan Trial for FSGS

Study: Glomerular Diseases Linked to Greater Risk of Cardivascular Disease

According to a story from Newswise, a recent study concluded that adult patients living with glomerular diseases face an increased chance of cardiovascular disease as well. The findings were first…

Continue Reading Study: Glomerular Diseases Linked to Greater Risk of Cardivascular Disease
Collaborative Study Highlights the Importance of Proteinuria in Focal Segmental Glomerulosclerosis
source: pixabay.com

Collaborative Study Highlights the Importance of Proteinuria in Focal Segmental Glomerulosclerosis

According to a story from BioSpace, a recent study conducted by the biotechnology company Goldfinch Bio in collaboration with academic partners is highlighting the importance of proteinuria in determining outcomes…

Continue Reading Collaborative Study Highlights the Importance of Proteinuria in Focal Segmental Glomerulosclerosis

High ROBO2 Protein Levels in Chronic Kidney Disease Point to a New Therapeutic Target

  According to a recent article in EurekaAlert, researchers at the University of Boston recently published their new study investigating ROBO2. The ROBO2 signaling pathway has emerged as a therapeutic…

Continue Reading High ROBO2 Protein Levels in Chronic Kidney Disease Point to a New Therapeutic Target
New Diagnostic Technique Helps to Predict Transplant Success in Those with Focal Segmental Glomerulosclerosis
sasint / Pixabay

New Diagnostic Technique Helps to Predict Transplant Success in Those with Focal Segmental Glomerulosclerosis

Focal segmental glomerulosclerosis (FSGS) is a kidney disease that often results in end-stage renal failure. A kidney transplant is the best way to treat this failure. The issue with this…

Continue Reading New Diagnostic Technique Helps to Predict Transplant Success in Those with Focal Segmental Glomerulosclerosis
Clinical Trials Underway for Potential Lupus Nephritis and FSGS Treatment
Source: Pixabay

Clinical Trials Underway for Potential Lupus Nephritis and FSGS Treatment

According to Business Wire, a pharmaceutical company, Aurinia Pharmaceuticals Inc., recently announced that they have enrolled the first lupus nephritis patients in the AURORA 2 extension study. Not only this, but Aurinia…

Continue Reading Clinical Trials Underway for Potential Lupus Nephritis and FSGS Treatment
Coworker Donates Her Kidney Just in Time to FSGS Patient
https://pixabay.com/en/girlfriends-hug-trust-girl-2213259/

Coworker Donates Her Kidney Just in Time to FSGS Patient

Carol Littrell and Cindy Hamilton were coworkers. And according to JDNews, Neither imagined they would ever become much closer than that. But everything changed by one chance encounter. Carol has…

Continue Reading Coworker Donates Her Kidney Just in Time to FSGS Patient